151 related articles for article (PubMed ID: 11303433)
1. Children, drugs, and the Food and Drug Administration: studies of pediatric drugs are beginning to catch up.
Ward RM
Pediatr Ann; 2001 Apr; 30(4):189-94. PubMed ID: 11303433
[No Abstract] [Full Text] [Related]
2. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.
Roberts R; Rodriguez W; Murphy D; Crescenzi T
JAMA; 2003 Aug; 290(7):905-11. PubMed ID: 12928467
[TBL] [Abstract][Full Text] [Related]
3. Improving pediatric dosing through pediatric initiatives: what we have learned.
Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
[TBL] [Abstract][Full Text] [Related]
4. New pediatric dosage rules: information and testing.
Feeg VD
Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
[No Abstract] [Full Text] [Related]
5. Pediatric testing of prescription drugs: the Food and Drug Administration's carrot and stick for the pharmaceutical industry.
Karst KR
Am Univ Law Rev; 2000; 49():739-72. PubMed ID: 11067732
[No Abstract] [Full Text] [Related]
6. FDA labeling status of pediatric medications.
Yoon EY; Davis MM; El-Essawi H; Cabana MD
Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220
[No Abstract] [Full Text] [Related]
7. Current status of the FDA approval process: comparison of requirements for pediatric and adult patients.
Robie-Suh KM
Inflamm Bowel Dis; 1998 May; 4(2):103-4. PubMed ID: 9687212
[No Abstract] [Full Text] [Related]
8. Is pediatric labeling really necessary?
Christensen ML; Helms RA; Chesney RW
Pediatrics; 1999 Sep; 104(3 Pt 2):593-7. PubMed ID: 10469796
[No Abstract] [Full Text] [Related]
9. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
[TBL] [Abstract][Full Text] [Related]
10. Off-label or off-limits?
Ritchey ML
J Urol; 2013 Jul; 190(1):8-9. PubMed ID: 23608037
[No Abstract] [Full Text] [Related]
11. FDA set to expand pediatric information in drug product labeling.
Am J Health Syst Pharm; 1995 Feb; 52(4):358. PubMed ID: 7757855
[No Abstract] [Full Text] [Related]
12. Nifedipine labeling illustrates the pediatric dilemma for off-patent drugs.
Adcock KG; Wilson JT
Pediatrics; 2002 Feb; 109(2):319-21. PubMed ID: 11826214
[No Abstract] [Full Text] [Related]
13. Ontogeny and the Application of Pharmacogenomics to Pediatric Drug Development.
Green D
J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S82-S86. PubMed ID: 31502695
[TBL] [Abstract][Full Text] [Related]
14. The FDA drug approval process: focus on pediatric labeling.
Brummel GL
Neonatal Netw; 2001 Apr; 20(3):49-51. PubMed ID: 12144214
[No Abstract] [Full Text] [Related]
15. Evaluating drugs for use in children.
Thompson RC
FDA Consum; 1975 Mar; 9(2):14-7. PubMed ID: 10308672
[No Abstract] [Full Text] [Related]
16. From the Food and Drug Administration.
Nightingale SL
JAMA; 1995 Jan; 273(4):279. PubMed ID: 7815644
[No Abstract] [Full Text] [Related]
17. Pediatric Drug Development: Outlook for Science-Based Innovation.
Green DJ; Zineh I; Burckart GJ
Clin Pharmacol Ther; 2018 Mar; 103(3):376-378. PubMed ID: 29384202
[TBL] [Abstract][Full Text] [Related]
18. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
Green W
Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
[No Abstract] [Full Text] [Related]
19. Analgesics for the treatment of pain in children.
Birenbaum D; Mattison DR
N Engl J Med; 2003 Mar; 348(10):959-60; author 959-60. PubMed ID: 12621144
[No Abstract] [Full Text] [Related]
20. New pediatric dosing information for Kaletra.
AIDS Patient Care STDS; 2008 Jul; 22(7):604. PubMed ID: 18661592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
